BmK CT and its radiolabeled derivatives, 125I-BmK CT and 131I-BmK CT, inhibited the expression of MMP-2, subsequently diminishing the invasiveness of glioma cells [50,51]. Here, MMP2 is linked to central nervous system cancer.